Cargando…

MicroRNAs in Animal Models of HCC

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality. Molecular heterogeneity and absence of biomarkers for patient allocation to the best therapeutic option contribute to poor prognosis of advanced stages. Aberrant microRNA (miRNA) expression is associated with HCC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fornari, Francesca, Gramantieri, Laura, Callegari, Elisa, Shankaraiah, Ram C., Piscaglia, Fabio, Negrini, Massimo, Giovannini, Catia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966618/ https://www.ncbi.nlm.nih.gov/pubmed/31805631 http://dx.doi.org/10.3390/cancers11121906

Ejemplares similares

Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs
por: Giovannini, Catia, et al.
Publicado: (2021)

MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2021)

Animal Models of Hepatocellular Carcinoma Prevention
por: Shankaraiah, Ram C., et al.
Publicado: (2019)

Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
por: Fornari, Francesca, et al.
Publicado: (2021)

Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research
por: Fornari, Francesca, et al.
Publicado: (2022)

MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2022)

Role of microRNAs in hepatocellular carcinoma: a clinical perspective
por: Callegari, Elisa, et al.
Publicado: (2013)

MicroRNA involvement in hepatocellular carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2008)

The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer
por: Roncarati, Roberta, et al.
Publicado: (2019)

MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
por: Callegari, Elisa, et al.
Publicado: (2018)

MicroRNAs as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing?
por: Gramantieri, Laura, et al.
Publicado: (2022)

Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC
por: Fornari, Francesca, et al.
Publicado: (2015)

Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
por: Giovannini, Catia, et al.
Publicado: (2023)

TP53/MicroRNA Interplay in Hepatocellular Carcinoma
por: Pollutri, Daniela, et al.
Publicado: (2016)

Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
por: Gramantieri, Laura, et al.
Publicado: (2022)

Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers
por: Gramantieri, Laura, et al.
Publicado: (2021)

Direct Antiviral Treatments for Hepatitis C Virus Have Off-Target Effects of Oncologic Relevance in Hepatocellular Carcinoma
por: Giovannini, Catia, et al.
Publicado: (2020)

LncRNAs as novel players in hepatocellular carcinoma recurrence
por: Gramantieri, Laura, et al.
Publicado: (2018)

Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2014)

MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma
por: Bergamini, Christian, et al.
Publicado: (2023)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives
por: Giovannini, Catia, et al.
Publicado: (2016)

Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2014)

Special role of Foxp3 for the specifically altered microRNAs in Regulatory T cells of HCC patients
por: Chen, Long, et al.
Publicado: (2014)

An Evolutionary Perspective of Animal MicroRNAs and Their Targets
por: Shomron, Noam, et al.
Publicado: (2009)

miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs
por: Lupini, Laura, et al.
Publicado: (2013)

The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma
por: Pollutri, Daniela, et al.
Publicado: (2018)

Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus
por: Callegari, Elisa, et al.
Publicado: (2013)

Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC
por: Granito, Alessandro, et al.
Publicado: (2021)

The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma
por: Crudele, Francesca, et al.
Publicado: (2021)

Systematic Analysis of Intestinal MicroRNAs Expression in HCC: Identification of Suitable Reference Genes in Fecal Samples
por: Wang, Hui, et al.
Publicado: (2019)

Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: study on a chemically-induced HCC mouse model
por: Del Vecchio, Filippo, et al.
Publicado: (2015)

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2018)

MicroRNAs as Haematopoiesis Regulators
por: Undi, Ram Babu, et al.
Publicado: (2013)

Computational prediction of disease microRNAs in domestic animals
por: Buza, Teresia, et al.
Publicado: (2014)

MicroRNAs as Biomarkers for Animal Health and Welfare in Livestock
por: Miretti, Silvia, et al.
Publicado: (2020)

Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5)
por: Terzi, Eleonora, et al.
Publicado: (2022)

MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
por: Ferracin, Manuela, et al.
Publicado: (2010)

Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV
por: De Matteis, Serena, et al.
Publicado: (2021)

MicroRNAs and senescence
por: Martinez, Ivan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bjkofrggm7rmt4kht4sm1nqnkr